等待开盘 09-10 09:30:00 美东时间
+0.240
+1.78%
Tactile Systems Technology shares are trading higher after the company reported...
08-05 20:45
Tactile Systems Tech (NASDAQ:TCMD) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.13 by 4.48 percent. This is a 30 percent decrease over earnings of $0.20 per share from
08-05 04:09
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is likely to rep...
08-04 16:32
富册金科(FTFT.US)今天宣布聘请英国萨里大学协理副校长、区块链与元宇宙应用研究院院长熊榆教授担任首席区块链顾问。
07-29 19:00
<p>Tactile Medical announced the release of its Q2 FY2025 financial results on August 4, 2025, after market close. A conference call with Q&A will follow at 5:00 p.m. ET on August 4. Participants can dial 877-407-3088 (201-389-0927 international) with access code 13754589. A live webcast is available at investors.tactilemedical.com. A replay will be available for two weeks at 877-660-6853 (201-612-7415 international) using the same access code. T...
07-21 20:05
<p>Late-stage data from Tactile Medical's Flexitouch Plus trial, presented at ASCO 2025, highlights its clinical and quality-of-life benefits for treating head and neck cancer-related lymphedema. The study, the largest randomized trial in the U.S., compares Flexitouch Plus, an advanced pneumatic compression device (APCD), with standard care. Key findings include faster therapy initiation (17.9 vs. 29.8 days), higher treatment receipt rate (94.9% ...
06-03 12:00
Tactile Systems Technology, Inc. (NASDAQ:TCMD) traded lower on Tuesday after th...
05-07 04:54
Earnings Call Insights: Tactile Systems Technology (TCMD) Q1 2025 Management View CEO Sheri Dodd highlighted that total revenue for Q1 2025 grew slightly by 0.3% year-over-year to $61.3 million. Howev...
05-06 11:00
Companies Reporting Before The Bell • Recursion Pharmaceuticals (NASDAQ:RXRX) i...
05-05 16:32
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1099253771533127680.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Stoke Therapeutics(STOK)"买入"评级,目标价从35美元升至47美元</p> <p>• D. Boral Capital:上调CervoMed(CR
02-20 09:10